Canada represents the world’s ninth biggest market for generic drugs in terms of value. Over the past few decades, the acceptance and use of generic drugs in Canada has changed significantly. The growth of the generic drug market in Canada has been catalysed by a number of factors. The continuous expiration of drug patents, rising aging population, increasing prevalence of chronic diseases and constant efforts by the government and health care service providers to control their healthcare expenditures have enabled generics to represent a multibillion dollar industry in Canada.

The report entitled “Canada Generic Drug Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026” represents an in-depth analysis on the historical, current and future trends in the generic drug market in Canada. This research report serves as an exceptional tool to understand the drivers, sales trends, prescription trends, market structure, competitive landscape, regulations, key players, key drugs, manufacturing and the outlook of the generic drug Market in Canada. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who want to gain an insight into the Canadian generic drug market in any form.

Key questions answered in this report:

What are generic drugs? How are they different from branded drugs?
How has the Canadian generic drug market performed in recent years?
How have generics performed compared to branded drugs?
What were the total sales and prescriptions for generic drugs in Canada?
Who are the key players in the Canadian generic drug market? How have they performed?
What has been the impact of COVID-19 on the Canada generic drug market?
What is the structure of the generic drug market in Canada?
What is the pricing mechanism of generic drugs in Canada?
What is the value chain of generic drugs in Canada?
What are the regulations for generic drugs in Canada?
How are generic drugs distributed in Canada?
How are generic drugs manufactured?
What are the raw material and machinery requirements to manufacture generic drugs?
What are the drivers and challenges in the generic drug market in Canada?